Cédric Lafond
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
Papers in
-
- Head and Neck Cancer Studies 5
- Oncology 2
- Cancer Diagnosis and Treatment 2
- Co-authors
- Yoann Pointreau (3 shared papers)G. Calais (3 shared papers)Philippe MAINGON (2 shared papers)Pascal Garaud (1 shared paper)Pierre Tremolieres (2 shared papers)Melanie Fesneau (1 shared paper)M. Lapeyre (2 shared papers)Sophie CHAPET (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Journal of Clinical Oncology (1 paper)Cancer/Radiothérapie (3 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Cédric Lafond
6 papers receiving 556 citations
Cédric Lafond's Hit Papers
Peers
Comparison fields: 5 of 36
- Otorhinolaryngology 282
- Oncology 290
- Immunology 87
- Pulmonary and Respiratory Medicine 100
- Cancer Research 32
Countries citing papers authored by Cédric Lafond
This map shows the geographic impact of Cédric Lafond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Lafond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Lafond more than expected).
Fields of papers citing papers by Cédric Lafond
This network shows the impact of papers produced by Cédric Lafond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Lafond. The network helps show where Cédric Lafond may publish in the future.
Co-authors
The 14 scholars most cited alongside Cédric Lafond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study Hit paper breakdown → | 2020 | 307 |
| 2 | Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial Hit paper breakdown → | 2022 | 133 |
| 3 | 2018 | 111 | |
| 4 | 2017 | 8 | |
| 5 | 2016 | 4 | |
| 6 | 2016 | 3 |
About Cédric Lafond
Cédric Lafond is a scholar working on Otorhinolaryngology, Oncology, Surgery, Insect Science and Renewable Energy, Sustainability and the Environment, having authored 6 papers that have together received 566 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (5 papers), Cancer Diagnosis and Treatment (2 papers) and Head and Neck Surgical Oncology (2 papers). The work is most often cited by research in Otorhinolaryngology (282 citations), Oncology (290 citations), Immunology (87 citations), Pulmonary and Respiratory Medicine (100 citations) and Cancer Research (32 citations). Cédric Lafond has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Yoann Pointreau, G. Calais, Philippe MAINGON, Pascal Garaud, Pierre Tremolieres, Melanie Fesneau, M. Lapeyre, Sophie CHAPET, Olivier Jean Marie Dupuis and A.V. Michaud Robert. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology and Cancer/Radiothérapie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.